1. A184 EARLY SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT-1 INDUCTION TRIAL. (7th March 2023) Authors: Danese, S; Dignass, A; Matsuoka, K; Ferrante, M; Long, M; Redondo, I; Gibble, T H; Moses, R; Morris, N; Li, X; Milch, C; Abreu, M; Jones, J Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 6(2023)Supplement 1 Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A185 SUSTAINED SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT-2 MAINTENANCE TRIAL. (7th March 2023) Authors: Dignass, A; Danese, S; Matsuoka, K; Ferrante, M; Long, M; Redondo, I; Gibble, T H; Moses, R; Li, X; Morris, N; Milch, C; Abreu, M; Jones, J Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 6(2023)Supplement 1 Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP01 Sequencing-based gene network analysis reveals a profound role for ferroptosis key gene GPX4 in post-operative endoscopic recurrence in Crohn's disease. (30th January 2023) Authors: Verstockt, S; Machiels, K; Dehairs, J; Rems, K; De Greef, I; Jans, D; Sabino, J; Ferrante, M; Vermeire, S; Verstockt, B Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP08 Mucosal healing with vedolizumab in inflammatory bowel disease patients with chronic pouchitis: Evidence from EARNEST, a randomized, double-blind, placebo-controlled trial. (30th January 2023) Authors: Jairath, V; Feagan, B G; Silverberg, M S; Danese, S; Gionchetti, P; Löwenberg, M; Bressler, B; Ferrante, M; Hart, A; Lindner, D; Escher, A; Jones, S; Shen, B; Travis, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP13 Postoperative Crohn's disease recurrence: unanswered questions and future directions in diagnosis, pathophysiology, prevention and treatment. Conclusions from the 8th ECCO Scientific workshop. (30th January 2023) Authors: Riviere, P; Dragoni, G; Allez, M; Allocca, M; Arebi, N; Bemelman, W; Bislenghi, G; Brown, S; Carvello, M; De Vries, A; Domenech, E; Hammoudi, N; Kapizioni, C; Kotze, P G; Mañosa, M; Myrelid, P; Oliveira-Cunha, M; Noor, N N; Pellino, G; Pouillon, L Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP17 Upadacitinib Improves Endoscopic Outcomes in Patients with Moderate to Severely Active Crohn's Disease Irrespective of Previous Failure to Respond to Biologics or Conventional Therapies. (30th January 2023) Authors: Feagan, B G; Horst, S; Dryden, G; Lindsay, J O; Ferrante, M; Dubenco, E; Lacerda, A P; Ford, S; Anyanwu, S I; Zhou, Q; Liu, J; Chen, M; Schreiber, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP19 Gaps between ECCO quality standards of care and the real world: the E-QUALITY survey. (30th January 2023) Authors: Fidalgo, C; Walsh, A; Adamina, M; Barreiro-Acosta, M; Burisch, J; Drobne, D; Faiz, O; Ferrante, M; Godny, L; Iacucci, M; Jäghult, S; Restellini, S; Rosini, F; Shouval, D; Yanai, H; Fiorino, G Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P005 0190Molecular-based classification of ulcerative colitis and its dynamic. (30th January 2023) Authors: Seyed Tabib, N S; Verstockt, S; Verstockt, B; Ferrante, M; Sabino, J; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P008 Fibrostricturing Crohn's disease is characterised by an imbalance in active eosinophils, Th1, Th2 and regulatory T cells. (30th January 2023) Authors: Jacobs, I; Ke, B J; Cremer, J; D'Hoore, A; Bislenghi, G; Matteoli, G; De Hertogh, G; Sabino, J; Ferrante, M; Vermeire, S; Breynaert, C; Vanuytsel, T; Verstockt, B Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P112 S1PR expression on circulating immune cells is not limited to lymphocytes in patients with inflammatory bowel disease. (30th January 2023) Authors: Verstockt ., B; Verstockt, S; Cremer, J; Sabino, J; Ferrante, M; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗